Logotipo do repositório
 

Publicação:
Therapeutic targets in chagas disease

Carregando...
Imagem de Miniatura

Orientador

Coorientador

Pós-graduação

Curso de graduação

Título da Revista

ISSN da Revista

Título de Volume

Editor

Tipo

Capítulo de livro

Direito de acesso

Acesso restrito

Resumo

Optimal pharmacotherapy occurs when we have selectivity and no toxicity. The discovery of specific pathways or enzymes that are vital forcell or parasite survival is also vital for the design of new specific, non-toxic drugs for the treatment of cancer, microbial or parasitic diseases. This chapter describes the main validated therapeutic targets in the research of new drugs for the treatment of Chagas' disease, such as cysteine proteases, ergosterol metabolic pathways, thiol-dependent mechanisms (trypanothione reductase), glycolytic pathways, transsialidase enzymes, the transport and metabolism of polyamines, among others, as well as examples from the scientific literature. This also includes what is already in clinical trials that involves the specified targets.

Descrição

Palavras-chave

Chagas' disease, Molecular targets, T. cruzi, Therapeutic targets

Idioma

Inglês

Como citar

Chagas Disease: Prevalence, Diagnosis and Treatment Options, p. 85-116.

Itens relacionados

Financiadores

Unidades

Departamentos

Cursos de graduação

Programas de pós-graduação